Your shopping cart is currently empty

Astringin (trans-Astringin) is an orally active natural flavonoid that mitigates oxidative stress and inflammatory responses by inhibiting the PI3K/AKT/NF-κB pathway. It also modulates TLR4/MyD88, HMGB1/RAGE, and NF-κB pathways to counteract chromium-induced nephrotoxicity, whilst inhibiting ferroptosis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $56 | - | In Stock | |
| 5 mg | $198 | - | In Stock | |
| 10 mg | $363 | - | In Stock | |
| 25 mg | $589 | - | In Stock | |
| 50 mg | $855 | - | In Stock | |
| 100 mg | $1,150 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $226 | - | In Stock |
| Description | Astringin (trans-Astringin) is an orally active natural flavonoid that mitigates oxidative stress and inflammatory responses by inhibiting the PI3K/AKT/NF-κB pathway. It also modulates TLR4/MyD88, HMGB1/RAGE, and NF-κB pathways to counteract chromium-induced nephrotoxicity, whilst inhibiting ferroptosis. |
| In vitro | In LPS-stimulated A549 cells, Astringin (0-75 µg/mL, 0-26 hours) enhanced cell viability, inhibited apoptosis, blocked the increase in ROS and MDA levels, and reduced the production of inflammatory factors such as TNF-α, IL-1β, and IL-6. Its mechanism of action is associated with the inhibition of the PI3K/AKT/NF-κB signaling pathway [1]. Astringin (1-100 µM) acted on Erastin-treated bone marrow mesenchymal stem cells and effectively inhibited lipid peroxidation [2]. |
| In vivo | After 4 weeks of intragastric administration, Astringin (10 mg/kg) effectively alleviated chromium-induced oxidative stress, inflammation, apoptosis, and renal tissue damage in rats [3]. |
| Synonyms | trans-Astringin |
| Molecular Weight | 406.38 |
| Formula | C20H22O9 |
| Cas No. | 29884-49-9 |
| Smiles | O([C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C2=CC(/C=C/C3=CC(O)=C(O)C=C3)=CC(O)=C2 |
| Relative Density. | no data available |
| Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (196.86 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (2.46 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.